Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes.

[1]  P. Oefner,et al.  Denaturing high‐performance liquid chromatography: A review , 2001, Human mutation.

[2]  X. Chen,et al.  Human ITCH is a coregulator of the hematopoietic transcription factor NF-E2. , 2001, Genomics.

[3]  Jie Fu,et al.  Localization of ribophorin II to the endoplasmic reticulum involves both its transmembrane and cytoplasmic domains , 2000, European Journal of Cell Biology.

[4]  P. Bryant,et al.  The genetics of the protein 4.1 family: organizers of the membrane and cytoskeleton. , 2000, Current opinion in cell biology.

[5]  Arrigo,et al.  Localization of p27 beta4 binding protein gene (ITGB4BP) to human chromosome region 20q11.2 , 1998, Genomics.

[6]  O. Olivieri,et al.  Decreased band 3 anion transport activity and band 3 clusterization in congenital dyserythropoietic anemia type II. , 1998, Experimental hematology.

[7]  B. Bonné-Tamir,et al.  Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3. , 1998, American journal of human genetics.

[8]  P. Gasparini,et al.  Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. , 1997, American journal of human genetics.

[9]  S. Perrotta,et al.  The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum. , 1996, Blood.

[10]  P. Marks,et al.  Congenital dyserythropoietic anemias , 1996, American journal of hematology.

[11]  G. Kreibich,et al.  Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 kd protein , 1992, Cell.

[12]  A. Dell,et al.  Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Dell,et al.  Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II. , 1987, The Journal of biological chemistry.

[14]  J. Delaunay,et al.  Abnormal fatty acid composition of erythrocyte glycosphingolipids in congenital dyserythropoietic anemia type II. , 1985, Journal of lipid research.

[15]  U. Testa,et al.  Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS) , 1984, British journal of haematology.

[16]  M. Tanner,et al.  Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia Type II (CDA II) , 1983, British journal of haematology.

[17]  H. Heimpel,et al.  Congenital Dyserythropoietic Anaemia, Types I and II: Aberrant Pattern of Erythrocyte Membrane Proteins in CDA II, as Revealed by Two‐dimensional Polyacrylamide Gel Electrophoresis , 1977, British journal of haematology.

[18]  G. Hug.  Congenital dyserythropoietic anemia type II , 1974, Definitions.

[19]  S. Lewis,et al.  Hereditary Erythroblastic Multinuclearity Associated with a Positive Acidified‐Serum Test: a Type of Congenital Dyserythropoietic Anaemia , 1969, British journal of haematology.

[20]  S. Perrotta,et al.  Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects. , 1996, Haematologica.

[21]  G. Holmgren,et al.  Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. , 1995, Human molecular genetics.

[22]  B. Lampkin,et al.  Congenital dyserythropoietic anemia type II: ultrastructural and radioautographic studies of blood and bone marrow. , 1972, Blood.